What we are studying
You have been asked to consider participating in a clinical study because you have been diagnosed with an abdominal aortic aneurysm (a bulge in the aorta; known as AAA). The goal of this study is to evaluate the ongoing safety and effectiveness of the the AFX® System compared to other similar devices by collecting data on your condition and the devices. All of the devices that will be assessed in this study are approved by the FDA for the treatment of abdominal aortic aneurysms and are commercially available in the United States. The AFX®device is made by Endologix, Inc. and Endologix is the sponsor, that is, will be paying for the study. The other devices that will be used in the study are Gore® EXCLUDER® AAA Endoprosthesis, Medtronic The Endurant® II AAA Stent Graft System, and Cook Zenith Flex® AAA Endovascular Graft all of these devices are intended to be used for the treatment of abdominal aortic aneurysms.